Alan Thomas Remaley
Impact in
- Cancer Research top 0.2%
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 86
- Surgery 170
- Cholesterol and Lipid Metabolism 97
- Lipoproteins and Cardiovascular Health 84
- Co-authors
- Kasey C. Vickers (11 shared papers)Robert D. Shamburek (28 shared papers)Bassem M. Shoucri (3 shared papers)Brian T. Palmisano (3 shared papers)Marcelo J. Amar (52 shared papers)H. Bryan Brewer (17 shared papers)Silvia Santamarina-Fojo (21 shared papers)John A. Stonik (26 shared papers)
- Journals
- Clinical Chemistry (27 papers)Journal of Lipid Research (24 papers)Journal of Biological Chemistry (20 papers)Arteriosclerosis Thrombosis and Vascular Biology (16 papers)Journal of clinical lipidology (12 papers)
- Partner nations
- United StatesAustraliaJapan
In The Last Decade
Alan Thomas Remaley
406 papers receiving 25.4k citations
Alan Thomas Remaley's Hit Papers
Peers
Comparison fields: 5 of 166
- Cancer Research 5.1k
- Endocrinology, Diabetes and Metabolism 4.9k
- Surgery 8.7k
- Molecular Biology 8.5k
- Immunology 2.5k
Countries citing papers authored by Alan Thomas Remaley
This map shows the geographic impact of Alan Thomas Remaley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Thomas Remaley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Thomas Remaley more than expected).
Fields of papers citing papers by Alan Thomas Remaley
This network shows the impact of papers produced by Alan Thomas Remaley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Thomas Remaley. The network helps show where Alan Thomas Remaley may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Thomas Remaley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 413 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins Hit paper breakdown → | 2011 | 2398 |
| 2 | PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway Hit paper breakdown → | 2001 | 1031 |
| 3 | Cholesterol Efflux and Atheroprotection Hit paper breakdown → | 2012 | 821 |
| 4 | Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine Hit paper breakdown → | 2016 | 622 |
| 5 | HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events Hit paper breakdown → | 2011 | 424 |
| 6 | 2008 | 412 | |
| 7 | A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia Hit paper breakdown → | 2020 | 399 |
| 8 | NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis Hit paper breakdown → | 2018 | 398 |
| 9 | 2014 | 364 | |
| 10 | 2010 | 307 | |
| 11 | 2007 | 292 | |
| 12 | 2001 | 289 | |
| 13 | 2001 | 284 | |
| 14 | 2012 | 281 | |
| 15 | High-density lipoprotein revisited: biological functions and clinical relevance Hit paper breakdown → | 2022 | 248 |
| 16 | HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research Hit paper breakdown → | 2021 | 244 |
| 17 | 2013 | 239 | |
| 18 | 2001 | 236 | |
| 19 | 2014 | 236 | |
| 20 | 1999 | 235 |
About Alan Thomas Remaley
Alan Thomas Remaley is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Cancer Research, Oncology and Immunology, having authored 413 papers that have together received 26.2k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (97 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (86 papers), Lipoproteins and Cardiovascular Health (84 papers), Cancer, Lipids, and Metabolism (47 papers), Drug Transport and Resistance Mechanisms (46 papers), Peroxisome Proliferator-Activated Receptors (36 papers), Atherosclerosis and Cardiovascular Diseases (15 papers) and Adipokines, Inflammation, and Metabolic Diseases (14 papers). The work is most often cited by research in Cancer Research (5.1k citations), Endocrinology, Diabetes and Metabolism (4.9k citations), Surgery (8.7k citations), Molecular Biology (8.5k citations) and Immunology (2.5k citations). Alan Thomas Remaley has collaborated with scholars based in United States, Australia and Japan. Frequent co-authors include Kasey C. Vickers, Robert D. Shamburek, Bassem M. Shoucri, Brian T. Palmisano, Marcelo J. Amar, H. Bryan Brewer, Silvia Santamarina-Fojo, John A. Stonik, Maureen L. Sampson and Edward B. Neufeld. Their work appears in journals such as Clinical Chemistry, Journal of Lipid Research, Journal of Biological Chemistry, Arteriosclerosis Thrombosis and Vascular Biology and Journal of clinical lipidology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.